NCT02118805View on ClinicalTrials.gov

Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Amyotrophic Lateral Sclerosis (ALS)Myasthenia GravisMyopathiesStrokeParkinson's Disease
Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT02118805 - Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders | Biotech Hunter | Biotech Hunter